None
Conditions
Interventions
Microencapsulated lutein esters group(Group A):25ml of drink was administered on the first day
Microencapsulated lutein ester and MCT group(Group B):25ml of microencapsulated lutein ester drink containing MCT was administered on the first day.
Microencapsulated lutein ester with MCT and low-dose black pepper extract group(Group C):25ml of microencapsulated lutein ester drink containing MCT and low-dose black pepper extract was administered
Microencapsulated lutein ester with MCT and medium-dose black pepper extract group(Group D):25ml of microencapsulated lutein ester drink containing MCT and medium-dose black pepper extract was adminis
Microencapsulated lutein ester with MCT and high-dose black pepper extract group(Group E):25ml of microencapsulated lutein ester drink containing MCT and high-dose black pepper extract was administere
Sponsors
Qingdao University
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Age 18-45 years and in good physical condition; No obvious diseases of the brain, heart, liver, lungs, kidneys, blood, etc.; Those who do not take long-term medication; Body mass index (BMI) is within the normal range; Those who voluntarily participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: People with severe metabolic diseases; People with severe chronic infections; Those who clearly know that they took nutritional supplements, hormones, drugs, such as various vitamins, minerals, etc. before the investigation; pregnant and lactating women; Smokers and alcoholics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma lutein concentration; | — |
Secondary
| Measure | Time frame |
|---|---|
| Body composition; | — |
Countries
China
Contacts
Public ContactAiguo Ma
Qingdao University
Outcome results
None listed